In essentially almost all human cancers, the powerful tumor suppressor function of p53 is compromised through a variety of mechanisms, such as amplification or upregulation of its negative regulators MDM2 and/or MDMX, or through the mutation or deletion of the TP53 gene. This evidence concerns the gene MDM4 and cancer.